1. Home
  2. COEP vs BGSF Comparison

COEP vs BGSF Comparison

Compare COEP & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • BGSF
  • Stock Information
  • Founded
  • COEP 2017
  • BGSF 2007
  • Country
  • COEP United States
  • BGSF United States
  • Employees
  • COEP N/A
  • BGSF N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • BGSF Professional Services
  • Sector
  • COEP Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • COEP 39.0M
  • BGSF 37.3M
  • IPO Year
  • COEP N/A
  • BGSF N/A
  • Fundamental
  • Price
  • COEP $9.31
  • BGSF $4.02
  • Analyst Decision
  • COEP
  • BGSF Strong Buy
  • Analyst Count
  • COEP 0
  • BGSF 1
  • Target Price
  • COEP N/A
  • BGSF $9.00
  • AVG Volume (30 Days)
  • COEP 107.6K
  • BGSF 20.3K
  • Earning Date
  • COEP 05-27-2025
  • BGSF 05-07-2025
  • Dividend Yield
  • COEP N/A
  • BGSF N/A
  • EPS Growth
  • COEP N/A
  • BGSF N/A
  • EPS
  • COEP N/A
  • BGSF N/A
  • Revenue
  • COEP N/A
  • BGSF $266,968,000.00
  • Revenue This Year
  • COEP N/A
  • BGSF $4.90
  • Revenue Next Year
  • COEP N/A
  • BGSF N/A
  • P/E Ratio
  • COEP N/A
  • BGSF N/A
  • Revenue Growth
  • COEP N/A
  • BGSF N/A
  • 52 Week Low
  • COEP $2.31
  • BGSF $2.91
  • 52 Week High
  • COEP $13.70
  • BGSF $9.26
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.50
  • BGSF 62.64
  • Support Level
  • COEP $7.81
  • BGSF $3.20
  • Resistance Level
  • COEP $10.86
  • BGSF $4.24
  • Average True Range (ATR)
  • COEP 1.45
  • BGSF 0.23
  • MACD
  • COEP 0.09
  • BGSF 0.12
  • Stochastic Oscillator
  • COEP 62.07
  • BGSF 78.91

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: